Bethesda Health Group to test Eli Lilly's antibody for Covid-19 prevention
November 18, 2020 at 15:52 PM EST
Bethesda Health Group, the St. Louis-based nonprofit provider of senior living and care services, is participating in a phase 3 clinical trial of Eli Lilly and Co.'s Covid-19 antibody treatment for its use in preventing the coronavirus.
